Maitreya Medicare (NSE:MAITREYA) Total Inventories: ₹8.44 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MAITREYA Maitreya Medicare Ltd NSE:MAITREYA
26 GF Score
Price ₹116.00
GF Value ₹459.99
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Maitreya Medicare Total Inventories?

Maitreya Medicare NSE:MAITREYA -4.13% 26 Total Inventories is ₹8.44 Mil as of Mar. 2026. GuruFocus rates NSE:MAITREYA with a GF Score™ of 26/100 and a GF Value™ of ₹459.99 (Possible Value Trap). The stock has 7 warning signs investors should review.

Maitreya Medicare's total inventories for the quarter that ended in Mar. 2026 was ₹8.44 Mil. Maitreya Medicare's average total inventories from the quarter that ended in Sep. 2025 to the quarter that ended in Mar. 2026 was ₹8.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Maitreya Medicare's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was ₹-3,235.32.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Maitreya Medicare's Days Inventory for the six months ended in Mar. 2026 was 3,034.20.

Inventory Turnover measures how fast the company turns over its inventory within a year. Maitreya Medicare's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.06.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Maitreya Medicare's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 3.78.


Maitreya Medicare  (NSE:MAITREYA) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Maitreya Medicare's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is

Net-Net Working Capital Per Share (Q: Mar. 2026 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(87.218+0.75 * 110.212+0.5 * 8.436-386.617
-0-7.48)/0.068
=-3,235.32

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Maitreya Medicare's Days Inventory for the six months ended in Mar. 2026 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2026 )/Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=7.997/0.481*365 / 2
=3,034.20

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Maitreya Medicare's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2026 ) / Average Total Inventories (Q: Mar. 2026 )
=0.481 / 7.997
=0.06

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Maitreya Medicare's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=7.997 / 2.115
=3.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Maitreya Medicare Total Inventories Related Terms


Maitreya Medicare Total Inventories Historical Data

* Premium members only.

The historical data trend for Maitreya Medicare's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maitreya Medicare Total Inventories Chart

Maitreya Medicare Annual Data
Trend Mar21 Mar22 Mar23 Mar25 Mar26
Total Inventories
13.66 6.87 7.99 0.00 8.44

Maitreya Medicare Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Sep24 Mar25 Sep25 Mar26
Total Inventories Get a 7-Day Free Trial 5.09 0.00 0.00 7.56 8.44
NSE:MAITREYA
26GF Score
Maitreya Medicare Ltd NSE:MAITREYA
Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maitreya Medicare Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of ₹8.44 Mil mean?
Maitreya Medicare (NSE:MAITREYA) has a Total Inventories of ₹8.44 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Maitreya Medicare and its competitors.
Is Maitreya Medicare's Total Inventories too high?
Maitreya Medicare's current Total Inventories is ₹8.44 Mil. Overall, Maitreya Medicare has a GF Score™ of 26/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Maitreya Medicare's Total Inventories compare to HCA and DVA?
Maitreya Medicare's Total Inventories of ₹8.44 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Healthcare Providers & Services company?
A good Total Inventories depends on the Healthcare Providers & Services industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Maitreya Medicare and its competitors. Maitreya Medicare's current Total Inventories is ₹8.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitreya Medicare stock overvalued right now?
Based on GuruFocus' analysis, Maitreya Medicare (NSE:MAITREYA) is currently considered Possible Value Trap. The stock's GF Value™ is ₹459.99, compared to a current price of ₹116.00 — trading 74.8% below its estimated fair value. The current Total Inventories is ₹8.44 Mil. Maitreya Medicare's overall GF Score™ is 26/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Maitreya Medicare (NSE:MAITREYA), the current Total Inventories is ₹8.44 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Maitreya Medicare (NSE:MAITREYA) Overvalued in 2026?

Based on GuruFocus' analysis, Maitreya Medicare stock appears to be undervalued. The current stock price of ₹116.00 is trading 74.8% below its estimated GF Value™ of ₹459.99. GuruFocus considers Maitreya Medicare to be Possible Value Trap.

Key valuation signals for NSE:MAITREYA:

  • Total Inventories: ₹8.44 Mil
  • GF Value™: ₹459.99 vs. price of ₹116.00 (74.8% below fair value)
  • GF Score™: 26/100 with 7 warning signs

No single metric tells the full story. See the NSE:MAITREYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Maitreya Medicare Business Description

Address Nr. Someshwara Char Rasta, Udhana - Magdalla Road, Surat, GJ, IND, 395007
Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
26GF Score

Get the complete analysis for NSE:MAITREYA

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹116.00
Price
₹459.99
GF Value